Showing results (661-670 of 686) with videos related to

Sort By:
Pageof 69
Clinical Biochemistry|February 15, 2026
Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)Victoria Higgins, Michelle L Parker, Basma Ahmed, et al.
Pediatric Neurology|March 4, 2017
Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke RegistryGabrielle A deVeber, Adam Kirton, Frances A Booth, et al.
Clinical Chemistry and Laboratory Medicine|January 16, 2020
An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresisKatherine A Turner, Jody L Frinack, Michael W Ettore, et al.
Clinical Chemistry and Laboratory Medicine|January 16, 2020
An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteinsJoannes F M Jacobs, Katherine A Turner, Maria Stella Graziani, et al.
Clinical Biochemistry|October 25, 2017
Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working GroupRonald A Booth, Christopher R McCudden, Cynthia M Balion, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Nature Biotechnology|February 4, 2026
Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurementMarsilea A Booth, Murat K Erdal, Mikel Larson, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
NPJ Vaccines|December 22, 2017
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKaruppiah Muthumani, Bryan D Griffin, Sangya Agarwal, et al.
Brain : a Journal of Neurology|February 7, 2025
De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndromeKevin T A Booth, Sharayu V Jangam, Martin M C Chui, et al.
Pageof 69